Title |
Relative resistance of HIV-1 founder viruses to control by interferon-alpha
|
---|---|
Published in |
Retrovirology, December 2013
|
DOI | 10.1186/1742-4690-10-146 |
Pubmed ID | |
Authors |
Angharad E Fenton-May, Oliver Dibben, Tanja Emmerich, Haitao Ding, Katja Pfafferott, Marlen M Aasa-Chapman, Pierre Pellegrino, Ian Williams, Myron S Cohen, Feng Gao, George M Shaw, Beatrice H Hahn, Christina Ochsenbauer, John C Kappes, Persephone Borrow |
Abstract |
Following mucosal human immunodeficiency virus type 1 (HIV-1) transmission, type 1 interferons (IFNs) are rapidly induced at sites of initial virus replication in the mucosa and draining lymph nodes. However, the role played by IFN-stimulated antiviral activity in restricting HIV-1 replication during the initial stages of infection is not clear. We hypothesized that if type 1 IFNs exert selective pressure on HIV-1 replication in the earliest stages of infection, the founder viruses that succeed in establishing systemic infection would be more IFN-resistant than viruses replicating during chronic infection, when type 1 IFNs are produced at much lower levels. To address this hypothesis, the relative resistance of virus isolates derived from HIV-1-infected individuals during acute and chronic infection to control by type 1 IFNs was analysed. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 1% |
Netherlands | 1 | <1% |
Unknown | 139 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 40 | 28% |
Researcher | 22 | 15% |
Student > Master | 18 | 13% |
Student > Bachelor | 12 | 8% |
Student > Doctoral Student | 7 | 5% |
Other | 15 | 11% |
Unknown | 28 | 20% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 42 | 30% |
Immunology and Microbiology | 33 | 23% |
Medicine and Dentistry | 17 | 12% |
Biochemistry, Genetics and Molecular Biology | 11 | 8% |
Social Sciences | 3 | 2% |
Other | 5 | 4% |
Unknown | 31 | 22% |